Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 13, 2021

SELL
$2.86 - $3.61 $680,657 - $859,151
-237,992 Closed
0 $0
Q1 2021

May 14, 2021

SELL
$2.61 - $4.08 $1.65 Million - $2.58 Million
-633,120 Reduced 72.68%
237,992 $819,000
Q4 2020

Feb 12, 2021

BUY
$1.82 - $2.61 $72,836 - $104,452
40,020 Added 4.82%
871,112 $2.2 Million
Q3 2020

Nov 13, 2020

BUY
$2.02 - $3.02 $346,987 - $518,763
171,776 Added 26.05%
831,092 $1.75 Million
Q2 2020

Aug 14, 2020

SELL
$2.12 - $3.22 $446,817 - $678,656
-210,763 Reduced 24.22%
659,316 $1.48 Million
Q1 2020

May 14, 2020

SELL
$1.82 - $3.87 $173,819 - $369,604
-95,505 Reduced 9.89%
870,079 $2.2 Million
Q4 2019

Feb 14, 2020

SELL
$2.57 - $3.68 $156,073 - $223,482
-60,729 Reduced 5.92%
965,584 $2.54 Million
Q3 2019

Nov 14, 2019

BUY
$3.01 - $4.0 $2.12 Million - $2.81 Million
702,698 Added 217.14%
1,026,313 $3.7 Million
Q2 2019

Aug 14, 2019

BUY
$2.79 - $4.31 $902,885 - $1.39 Million
323,615 New
323,615 $1.09 Million

Others Institutions Holding ENZ

About ENZO BIOCHEM INC


  • Ticker ENZ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 48,720,500
  • Market Cap $48.7M
  • Description
  • Enzo Biochem, Inc., an integrated diagnostics, clinical lab, and life sciences company, researches, develops, manufactures, and markets diagnostic and research products based on genetic engineering, biotechnology, and molecular biology. It operates through three segments: Life Sciences Products, Clinical Laboratory Services, and Therapeutics. Th...
More about ENZ
Track This Portfolio

Track Ariel Investments, LLC Portfolio

Follow Ariel Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ariel Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ariel Investments, LLC with notifications on news.